18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:2/17/2019
Start Date:August 2, 2017
End Date:April 2021
Contact:Andrea Otte, DPT
Email:anotte@stanford.edu
Phone:(650) 736-4183

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The investigators will evaluate the detection of cardiac sarcoidosis or inflammation using
18F-FSPG PET/MRI.

PET/MRI scans will be performed with a whole-body PET/MR imaging system capable of
simultaneous PET and MR imaging (SIGNA, GE Healthcare, Milwaukee, WI). Approximately 45-60
minutes after IV injection of 8 mCi of 18F-FSPG, PET emission scanning and MRI acquisition T1
weighted scanning will begin imaging both whole body and the heart.

Inclusion Criteria:

- Patient is ≥ 18 years old at the time of the scan

- Patient with known or suspected cardiac sarcoidosis.

- Patient is capable of complying with study procedures

- Patient can remain still for duration of imaging procedure

Exclusion Criteria:

- Patient is pregnant or nursing

- Metallic implants (contraindicated for MRI)

- History of renal insufficiency (only for MRI contrast administration)
We found this trial at
1
site
Stanford University
450 Serra Mall
Stanford, California 94305
(650) 723-2300
Phone: 650-736-4183
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
?
mi
from
Stanford, CA
Click here to add this to my saved trials